Features
Screener
Pricing
Resources
About
en
Features
Screener
Pricing
Resources
About
Language
en
Login
Start for free
DISCOVER
Screener
Stocks
ETF
Crypto
SCPI
Trending
Comparator
Calendar
Charting
Super investors
SOCIAL
Community
Public portfolios
/
Image Modal
Image Modal Description
Tibet Cheezheng Tibetan Medicine Co., Ltd.
002287.SZ
-
CNE100000FM9
Compare
Last update : Aug 28, 2026 at 23:20
General
Scores
Financials
Ratios
Valuation
Dividend
Exposure
Analysts
Insider
Tibet Cheezheng Tibetan Medicine Co., Ltd. (002287.SZ) Dividend, Growth and Profitability Scores - Invvest
Dividend
Last update : Jul 31, 2026
8
SpVo2
Metrics
Value
Rating
Payout ratio
85
SgLmi
AHJFx
Free cash flow payout ratio
40
I87XM
4L4wd
3Y Earnings growth
83
xOjhF
PivwY
Dividend streak
20
zzRQz
460Ae
Dividend growth streak
45
ckvFt
2G83w
5Y Dividend growth
99
VK2mB
Jfu9F
15Y Dividend cut
89
5BgLI
C6wbO
15Y Dividend interruption
68
hj3tb
wjiRR
Return on equity
14
bJze6
zjW7q
Net debt / EBITDA
5
28OIj
JMss0
Interest coverage
44
UQNFg
XLkrG
Growth
Last update : Jul 30, 2026
14
xa6qgEy
Metrics
Value
Rating
Revenue growth
58
V1ttD
hAC2k
5Y Revenue growth
75
KA8jN
jctot
EBITDA growth
78
CLmcD
Financial Strength
Last update : Jul 30, 2026
15
H8sDKO
Metrics
Value
Rating
Interest coverage
46
fbOuV
S1fH1
Quick ratio
17
dSZFZ
diDmx
Debt / Assets
82
Qgxyw
Profitability
Last update : Jul 30, 2026
4
XHuSqJ79
Metrics
Value
Rating
Gross margin
11
03OXO
pMQYk
Operating margin
95
hx7Ts
E1cLz
Net margin
18
ZRuHX
6WPmd
Momentum
Last update : Aug 23, 2026
12
6m4fZH
Metrics
ESG
No data available currently
Piotroski F
Last update : Aug 4, 2026
3
Unlock this feature
0
3
6
9
Altman Z
Last update : Aug 4, 2026
2
Unlock this feature
0 and -
1.8
3
4.5 and +
qsWJO
5Y EBITDA growth
75
TkprB
slW0E
Operating income growth
61
InxAj
Fu1tJ
5Y Operating income growth
48
4GM3L
wB9ta
Net income growth
44
IwgYl
MLxlm
Free cash flow growth
69
kxpWE
uBl2E
5Y Free cash flow growth
79
rHjRP
qjloz
Operating cash flow growth
87
eAzsG
KipYY
5Y Operating cash flow growth
65
zbBCl
idJyN
Capex growth
60
hFnr9
Bez6p
35HUr
Debt / Equity
94
FlSTz
Fxg5p
Net debt / EBITDA
31
jz8fD
W8q3I
Cash / Debt
13
An4Yi
4zDrY
Altman Z Score
74
Tq0Lj
mA3N6
Piotroski F Score
92
WMNMF
79C7s
Capex coverage ratio
1
VhAGK
lpum7
Free cash flow margin
33
k49BI
VRJrr
Return on invested capital
20
PmmCb
wdRDq
Return on equity
28
ws6zS
yapnt
Return on assets
16
86j48
dWUOO
Capex / Revenue
26
2jpmY
GwLxG
Profitable years 5Y
25
9yen5
Wnjz2
Value
Rating
SMA 50 vs Price
2
AUmQP
2t7Hd
SMA 200 vs Price
71
0IMni
knGuf
SMA 50 vs SMA 200
81
fIcbI
DOo66
1M Decile rank
25
cSrOd
lBH8Z
6M Decile rank
17
CA9Rk
1EJIw
1Y Decile rank
47
6wEQP
ddaZg
